Average of Glucose in Blood: UK Guide

The average of glucose in blood is a key indicator of metabolic health, reflecting how well your body regulates blood sugar over time. Whether you are managing diabetes, monitoring prediabetes, or simply keeping an eye on your health, understanding what your average blood glucose means, how it is measured, and what affects it can help you make informed decisions. This article explains the relevant tests used in UK clinical practice, normal reference ranges, common causes of abnormal levels, and when to seek medical advice.

What does your average blood glucose level actually mean?

Average blood glucose reflects how much sugar has circulated in your bloodstream over time, most commonly summarised by the HbA1c test, which covers approximately two to three months but weights recent weeks more heavily.

Your average blood glucose level is a measure of how much glucose (sugar) has been circulating in your bloodstream over a given period of time. Glucose is the body's primary fuel source, derived mainly from carbohydrates in food. After eating, the digestive system breaks carbohydrates down into glucose, which passes into the bloodstream and triggers the pancreas to release insulin. Insulin acts like a key, allowing glucose to enter cells where it is used for energy.

When this system works well, blood glucose rises modestly after meals and returns to a baseline level within a couple of hours. When it does not work well, glucose can remain persistently elevated (hyperglycaemia) or drop too low (hypoglycaemia), both of which carry health consequences.

The term 'average blood glucose' is most commonly discussed in the context of a laboratory test called HbA1c (glycated haemoglobin), which reflects average glucose exposure over approximately two to three months. Importantly, HbA1c is a weighted average: glucose levels from the most recent four to eight weeks contribute more to the result than those from earlier in the period, so it does not capture day-to-day variability or the frequency of high or low episodes. This is distinct from a single fingerprick reading, which only captures glucose at one moment in time. Understanding the difference between these two measures is important for anyone managing or monitoring their metabolic health, whether they have a diagnosis of diabetes or are being assessed for prediabetes.

How is average blood glucose measured in the UK?

HbA1c is the primary NHS measure, reported in mmol/mol; continuous glucose monitoring and fingerprick testing are also used depending on clinical need and diabetes type.

In the UK, the primary method for assessing average blood glucose is the HbA1c blood test, which is recommended by NICE and used routinely in NHS practice for diagnosing type 2 diabetes and monitoring glycaemic control in people already living with diabetes.^[1][5] HbA1c measures the percentage of haemoglobin molecules in red blood cells that have glucose attached to them. Because red blood cells live for roughly 120 days, the result reflects average glucose levels over approximately that period, though recent weeks are weighted more heavily.^[14]

HbA1c is reported in millimoles per mole (mmol/mol) in the UK, following the IFCC (International Federation of Clinical Chemistry) standardisation adopted by the NHS.^[1] You may also see it expressed as a percentage in older literature or from international sources, but mmol/mol is the current UK standard.

HbA1c is not reliable in all situations. It may give misleading results in people with haemoglobinopathies (such as sickle cell disease or thalassaemia), significant anaemia or altered red blood cell turnover, advanced chronic kidney disease, or those who have had a recent blood transfusion.^[1][5] It is also not recommended for diagnosing diabetes during pregnancy, in children, or where type 1 diabetes is suspected or acute hyperglycaemia is present. In these situations, fasting plasma glucose or an oral glucose tolerance test (OGTT) is used instead. Your GP or diabetes team will advise which test is appropriate for you.

For people who require more frequent monitoring, such as those on insulin therapy, continuous glucose monitoring (CGM) devices are available on the NHS. NICE recommends that CGM (including real-time CGM) is routinely offered to adults with type 1 diabetes. For adults with type 2 diabetes, CGM may be considered for those on insulin who meet specific clinical criteria, in line with NICE guidance (NG28). CGM sensors worn on the skin measure interstitial glucose in real time and can calculate a metric called 'time in range', which complements HbA1c by showing how much of the day glucose stays within a target band. Fingerprick testing using a glucometer remains widely used and provides an immediate snapshot of blood glucose at a specific moment, but it does not on its own reflect the average over time. Your GP or diabetes care team will advise which combination of tests is most appropriate for your situation.

What are the normal blood glucose ranges for adults in the UK?

A normal fasting blood glucose is 3.9 to 5.4 mmol/L and a normal HbA1c is below 42 mmol/mol; 48 mmol/mol or above on two tests is diagnostic of type 2 diabetes.

For most adults without diabetes in the UK, a fasting blood glucose level of 3.9 to 5.4 mmol/L is considered within the normal range, and a level below 7.8 mmol/L two hours after eating is generally regarded as normal. These figures are consistent with NHS and NICE guidance.

For HbA1c, NICE (NG28) and NHS guidance define the following thresholds:

• Below 42 mmol/mol: Normal (no diabetes)

• 42 to 47 mmol/mol: Non-diabetic hyperglycaemia (sometimes called prediabetes), indicating an elevated risk of developing type 2 diabetes

• 48 mmol/mol or above: Diagnostic of type 2 diabetes (when confirmed on a second test, or alongside symptoms)

For people already diagnosed with type 2 diabetes, NICE recommends an individualised HbA1c target. A target of 48 mmol/mol (6.5%) is commonly used for those managed by lifestyle alone or with metformin. Where there is a meaningful risk of hypoglycaemia, for example in people taking sulphonylureas or insulin, a less stringent target of 53 mmol/mol (7.0%) is often more appropriate. Targets may also be adjusted based on age, frailty and other clinical factors.

For people with type 1 diabetes, NICE (NG17) recommends aiming for an HbA1c of 48 mmol/mol or below where this can be achieved safely without problematic hypoglycaemia.^[2]

It is important to note that these are population-level reference ranges. Individual targets should always be agreed with a GP or diabetes specialist, as what is appropriate varies considerably between people.

What causes your average blood glucose to be too high or too low?

High average blood glucose is most commonly caused by type 2 or type 1 diabetes, insulin resistance, poor diet or certain medications; low levels are most often linked to insulin or sulphonylurea use, alcohol or prolonged fasting.

Persistently high average blood glucose (hyperglycaemia) is most commonly caused by type 2 diabetes, type 1 diabetes, or non-diabetic hyperglycaemia (prediabetes), conditions in which the body either does not produce enough insulin or cannot use it effectively. Other causes include:

• Dietary factors: A diet consistently high in refined carbohydrates and sugars

• Physical inactivity: Reduced muscle uptake of glucose

• Obesity: Excess adipose tissue, particularly visceral fat, contributes to insulin resistance

• Certain medications: Corticosteroids, some antipsychotics and thiazide diuretics can raise blood glucose; these effects may be transient or ongoing depending on the duration of treatment^[12]

• Hormonal conditions: Polycystic ovary syndrome (PCOS), Cushing's syndrome and acromegaly can impair glucose regulation

• Stress and illness: Both physical and psychological stress raise cortisol, which in turn raises blood glucose; acute illness can cause a temporary rise that does not necessarily indicate diabetes

Low average blood glucose (hypoglycaemia) is less common in people without diabetes but can occur with:

• Certain diabetes medications: Particularly insulin and sulphonylureas, which can lower glucose too far

• Excessive alcohol consumption: Alcohol inhibits the liver's ability to release stored glucose

• Prolonged fasting or under-eating

• Rare conditions: Such as insulinoma (an insulin-secreting tumour) or Addison's disease

Understanding the underlying cause is essential, as treatment differs significantly depending on whether glucose is too high or too low, and why.

How can you bring your average blood glucose back into a healthy range?

Dietary changes, regular physical activity and weight management are the cornerstones of treatment; metformin is the first-line medication for type 2 diabetes under NICE guidance when lifestyle changes are insufficient.

Bringing average blood glucose back into a healthy range depends on the underlying cause, but lifestyle modification is the cornerstone of management for most people, particularly those with non-diabetic hyperglycaemia or early type 2 diabetes. NICE guidance (NG28) supports the following approaches:

Diet: Reducing intake of refined carbohydrates, sugary drinks and ultra-processed foods, while increasing fibre, vegetables, lean protein and healthy fats, can meaningfully lower blood glucose. Low-calorie and low-carbohydrate dietary patterns have both shown benefit in clinical evidence reviewed by NICE.

Physical activity: Regular aerobic exercise (such as brisk walking, cycling or swimming) and resistance training improve insulin sensitivity. NHS guidelines recommend at least 150 minutes of moderate-intensity activity per week for adults, alongside muscle-strengthening activities on at least two days per week.^[13]

Weight management: Even modest weight loss of 5 to 10% of body weight can significantly improve glycaemic control in people with type 2 diabetes or non-diabetic hyperglycaemia, as supported by NICE NG28.^[1][5]

Medication: Where lifestyle changes are insufficient, a GP may prescribe glucose-lowering medicines. Metformin remains the first-line pharmacological option for type 2 diabetes in NICE guidance.^[9][1] For people with obesity and type 2 diabetes or those requiring additional weight management support, GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists may be considered, subject to clinical eligibility and NHS or private availability. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where clinically appropriate options may be discussed.

Monitoring: Keeping track of blood glucose, whether through HbA1c tests, fingerprick readings or CGM, helps you and your healthcare team assess whether interventions are working and adjust the plan accordingly.

When should you see a GP about your blood glucose levels?

See a GP if you have symptoms such as increased thirst, frequent urination or fatigue, or an unexpected test result; call 999 immediately if DKA or severe hypoglycaemia is suspected.

You should see your GP if you notice symptoms that may suggest your blood glucose is outside a healthy range, or if a home test or pharmacy check has returned an unexpected result. Symptoms that warrant a GP appointment include:

• Increased thirst or a persistently dry mouth

• Passing urine more frequently than usual, particularly at night

• Unexplained fatigue or low energy

• Blurred vision

• Slow-healing cuts or wounds

• Recurrent infections, such as thrush or urinary tract infections

• Unintentional weight loss

These can be signs of undiagnosed or poorly controlled diabetes and should not be ignored. If you have a family history of type 2 diabetes, are living with obesity, have PCOS, or are from a South Asian, Black African or Black Caribbean background (groups at higher risk at lower BMI thresholds), it is worth discussing routine screening with your GP even in the absence of symptoms.^[10][11]

Suspected new-onset type 1 diabetes, particularly in children, young adults or during pregnancy, requires urgent same-day assessment. Do not wait for a routine appointment if symptoms have developed rapidly or are severe.

Seek urgent medical attention or call 999 if you or someone with you develops symptoms that may suggest diabetic ketoacidosis (DKA) or hyperosmolar hyperglycaemic state (HHS). These include abdominal pain, vomiting, deep or rapid breathing, drowsiness or confusion, or a positive ketone reading alongside high blood glucose. These are medical emergencies.

For people already diagnosed with diabetes, contact your GP or diabetes nurse if your readings are consistently outside your agreed target range or if you are experiencing frequent hypoglycaemic episodes. If you or someone with you experiences severe hypoglycaemia with confusion, loss of consciousness or seizures, call 999 immediately. For urgent advice that does not require an emergency response, NHS 111 is available 24 hours a day.

Suspected side effects from any diabetes medication can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Scientific References

1. Type 2 diabetes in adults: management (NG28) – Recommendations.
2. Type 1 diabetes in adults: diagnosis and management (NG17) – Recommendations.
3. Continuous glucose monitoring | Type 1 diabetes in adults (QS208).
4. Continuous glucose monitoring for adults who use insulin and need help monitoring their blood glucose (QS209).
5. Blood glucose management | Type 2 diabetes in adults (NG28).
6. Type 2 diabetes: prevention in people at high risk (PH38).
7. Diabetes in pregnancy: management from preconception (NG3).
8. Diabetes (type 1 and type 2) in children and young people (NG18).
9. Type 2 diabetes in adults: choosing medicines for first-line and further treatment (NG28 visual summary).
10. Referring people at high risk of type 2 diabetes (QS167).
11. Appendix A1: Summary of evidence from surveillance (NG246) – lower BMI thresholds for South Asian and Chinese populations.
12. High blood sugar (hyperglycaemia).
13. Physical activity guidelines for adults aged 19 to 64.
14. Reference interval for glycated hemoglobin (HbA1c) in non-pregnant, non-diabetic women in Ethiopia: a cross-sectional study. Pan African Medical Journal. PMID 41624695..

Frequently Asked Questions